OW
SummitIn personPast event
2nd Obesity & Weight Loss Drug Development Summit Europe
Hosted by Hanson Wade
- 28 – 29 October 2026
- Hyperion Hotel München, Munich, Germany
- Health SciencesPharmacy & Pharmaceutical SciencesMedical & Health SciencesClinical Medicine
Let others know you'll be there. This does not register you for the event.
Welcome to kongre.net
Welcome to kongre.net
Registration
Event has endedRegistration is handled by the organiser
Key facts
2nd Obesity & Weight Loss Drug Development Summit Europe is a summit held 28 – 29 October 2026 in Hyperion Hotel München, Munich, Germany, organised by Hanson Wade.
- Dates:
- 28 – 29 October 2026
- Format:
- In person
- Venue:
- Hyperion Hotel München, Munich, Germany
- Subjects:
- Pharmacy & Pharmaceutical Sciences, Clinical Medicine
- Organiser:
- Hanson Wade
- Official website:
- obesity-drug-development-europe.com
The 2nd Obesity & Weight Loss Drug Development Summit Europe is an industry-centred forum exploring new mechanisms of action, combination therapies, and tolerability improvements to define the next generation of obesity and weight loss therapeutics.
Conference theme
Defining the Second Wave of Competitive & Efficacious Weight Loss Therapeutics
Objectives
To engage with leading innovators and stakeholders to advance the next wave of obesity therapeutics beyond first-generation GLP-1s, uncover innovative targets, emerging combinations, and patient phenotyping approaches.
Who should attend
Drug developers, research organizations, and academic institutions.
Programme highlights
View full programme- Wed, 28 Oct 2026Panel & Audience Discussion: Evaluating Oral, Injectable & DNA Delivery Methods to Align Modality Selection with Clinical Performance & Commercial ScalePanel14 sessions this day
- Thu, 29 Oct 2026Panel Discussion: Evaluating Opportunities to Improve Long-Term Weight Loss ManagementPanel12 sessions this day
Speakers
View all 20 speakersPipeline & Commercialisation Strategy Head, Constructive Bio
Industry Leaders Fireside Chat: Driving Access, Therapeutic Advances & Scale to Position Europe as the Next Obesity Innovation HubChief Executive & Scientific Officer, iBio
Unlocking Superior Obesity Outcomes by Preserving Muscle While Maximizing Fat LossSenior Vice President & Global Head of Research & Early Development, Bayer
Exploring GIP Pathways to Combat Obesity & Diabetes to Decrease ComorbiditiesChief Business Officer, Senovia Biosciences
Unlocking the Potential of Ketosis to Enhance Effective, Maintainable Weight Loss +1 more
Organiser and contact
Contact
- Event secretary:
- Darja Kielthy
- Email:
- [email protected]
Advertisement
Related events
- MEDICA 2026Düsseldorf, Germany16–19 Nov 2026
- ESMO AI & Digital Oncology Congress 2026Berlin, Germany16–18 Nov 2026
- 19th Clinical Trials on Alzheimer's Disease (CTAD)Boston, United States of America16–19 Nov 2026
- EHA Topics-in-Focus Preceptorship on Hemoglobinopathies: From Diagnosis and Prevention, to Personalized Management and CureAthens, Greece16–18 Nov 2026
- BIO Partnering™ @ Life Sciences Week 2026London, United Kingdom16–19 Nov 2026
- Targeted Patient Recruitment SummitBoston, United States of America17–19 Nov 2026